Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.
5. Making it onto our list at number five is the announcement that the FDA has approved Amgen’s new preventative migraine treatment, Aimovig.
New preventative migraine treatment from Amgen receives FDA approval
4. Number four for this week is the cover story from our latest May issue from Natoli, looking at how the right tooling can help overcome the challenges in tablet manufacturing.
Time for change — how the right tooling can help overcome the challenges of tablet manufacture
3. Our recently published article from VWV looking at how pharma can learn from the collapse of the construction giant Carillion takes third place.
Never too big to fail… and other lessons pharma can learn from Carillion
2. Coming in as our runner up is the announcement that the FDA has published a ‘name and shame’ list of those companies potentially using gaming tactics to delay generics.
FDA publishes list of companies that have potentially used ‘gaming’ tactics to delay generics
1. This week’s top spot goes to the upcoming webinar from Thermo Fisher Scientific that will be hosted by us at EPM on how informatics can enforce lab best practices.